BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

UCB Research Inc. 

840 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: Fax: 617-547-8481


SEARCH JOBS


UCB Research, Inc., located in Cambridge, Massachusetts, is a cutting edge research and discovery company which supports UCB Pharma's drug development pipeline with therapeutic candidates for allergic and central nervous system disorders. Our research utilizes state-of-the-art tools for target discovery, chemistry and pharmacology. We maintain an entrepreneurial environment that encourages personal initiative. Therefore, we have created a dynamic and innovative working environment with a broad range of drug discovery capabilities.

UCB Research is a subsidiary of UCB Pharma, a global research-based pharmaceutical company with 6,500 employees based in Brussels, Belgium and with U.S. headquarters in Atlanta, Georgia. The company is a global leader in the research, manufacture, and marketing of innovative therapeutics for allergy and central nervous system disorders. UCB Pharma's products include Zyrtec® (ceterizine HCl), globally the leading antihistamine, and Keppra® (levetiracetam), a novel anti-epileptic drug approved in the U.S. and Europe in 2000.

UCB Pharma is part of the UCB Group, which in addition to pharmaceuticals, includes a films and coatings sector, Surface Specialties. UCB Group currently employs over 10,000 people worldwide. The company's two sectors seek to promote health, well being and an improved quality of life.

Last Updated: 03-11-05



 Key Statistics


Email:
Ownership: Private

Web Site: UCB Research Inc.
Employees: 100 (Cambridge) 10,000 (Globally)
Symbol: 
 









 Company News